Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Apr 18;11(4):553.
doi: 10.3390/cancers11040553.

MicroRNA-Based Diagnosis and Treatment of Metastatic Human Osteosarcoma

Ryo Sasaki  1 , Mitsuhiko Osaki  2   3 , Futoshi Okada  4   5
Affiliations
Review

MicroRNA-Based Diagnosis and Treatment of Metastatic Human Osteosarcoma

Ryo Sasaki et al. Cancers (Basel). .

Abstract

Osteosarcoma is a malignant tumor of the bones that commonly occurs in young individuals. The 5-year survival rate of osteosarcoma patients is 60-70%. Metastasis to the lungs leads to death in 30-40% of osteosarcoma patients. Therefore, the development of effective strategies for early detection and treatment of this disease are important to improve the survival of osteosarcoma patients. However, metastatic markers for osteosarcoma and molecules that might be targeted for the treatment of metastatic osteosarcoma have not been identified yet. Therefore, the mechanism of metastasis to the lungs needs to be explored from a novel viewpoint. Recently, the aberrant expression of microRNAs (miRNAs) has been reported to be involved in the carcinogenesis and cancer progression of many cancers. Furthermore, miRNAs in the blood have been reported to show an aberrant expression unique to several cancers. Therefore, miRNAs are gaining attention as potential diagnostic markers for cancers. On the other hand, normalizing the dysregulated expression of miRNAs in cancer cells has been shown to alter the phenotype of cancer cells, and thus treatment strategies targeting miRNAs are also being considered. This review summarizes the abnormality of miRNA expression associated with the metastasis of osteosarcoma and describes the present situation and issues regarding the early diagnosis and development of treatment strategies for metastatic osteosarcoma based on the current understanding of this disease.

Keywords: lung metastasis; microRNA; osteosarcoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Dysregulated miRNAs and their target genes related to metastasis of osteosarcoma.
Figure 2
Figure 2
Challenges for miRNA-based cancer therapy development.
See this image and copyright information in PMC

References

    1. Mirabello L., Troisi R.J., Savage S.A. Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the surveillance, epidemiology, and end results program. Cancer. 2009;115:1531–1543. doi: 10.1002/cncr.24121. - DOI - PMC - PubMed
    1. Biermann J.S., Adkins D.R., Agulnik M., Benjamin R.S., Brigman B., Butrynski J.E., Cheong D., Chow W., Curry W.T., Frassica D.A., et al. Bone cancer. J. Natl. Compr. Cancer Netw. 2013;11:688–723. doi: 10.6004/jnccn.2013.0088. - DOI - PubMed
    1. Mirabello L., Troisi R.J., Savage S.A. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int. J. Cancer. 2009;125:229–234. doi: 10.1002/ijc.24320. - DOI - PMC - PubMed
    1. Damron T.A., Ward W.G., Stewart A. Osteosarcoma, chondrosarcoma, and Ewing’s sarcoma: National Cancer Data Base Report. Clin. Orthop. Relat. Res. 2007;459:40–47. doi: 10.1097/BLO.0b013e318059b8c9. - DOI - PubMed
    1. Luetke A., Meyers P.A., Lewis I., Juergens H. Osteosarcoma treatment—Where do we stand? A state of the art review. Cancer Treat. Rev. 2014;40:523–532. doi: 10.1016/j.ctrv.2013.11.006. - DOI - PubMed

LinkOut - more resources